Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 291
mi
from
Hoffman Estates, IL
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 291
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 218
mi
from
Evansville, IN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 218
mi
from
Evansville, IN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 158
mi
from
Madisonville, KY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 158
mi
from
Madisonville, KY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 270
mi
from
Mandeville, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 270
mi
from
Mandeville, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 214
mi
from
Marrero, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 214
mi
from
Marrero, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 188
mi
from
Metairie, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 188
mi
from
Metairie, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 432
mi
from
Shreveport, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 432
mi
from
Shreveport, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 271
mi
from
Bangor, ME
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 271
mi
from
Bangor, ME
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 160
mi
from
Annapolis, MD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 160
mi
from
Annapolis, MD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 255
mi
from
Towson, MD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 255
mi
from
Towson, MD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 267
mi
from
Brockton, MA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 267
mi
from
Brockton, MA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 260
mi
from
Ann Arbor, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 260
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 283
mi
from
Buckley, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 283
mi
from
Buckley, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 239
mi
from
Flint, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 239
mi
from
Flint, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 168
mi
from
Troy, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 168
mi
from
Troy, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 216
mi
from
Wyoming, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 216
mi
from
Wyoming, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 221
mi
from
Biloxi, MS
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 221
mi
from
Biloxi, MS
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 282
mi
from
Jefferson City, MO
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 282
mi
from
Jefferson City, MO
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 156
mi
from
Billings, MT
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 156
mi
from
Billings, MT
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 275
mi
from
Las Vegas, NV
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 275
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 175
mi
from
Vineland, NJ
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 175
mi
from
Vineland, NJ
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 293
mi
from
Albuquerque, NM
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 293
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 151
mi
from
Brooklyn, NY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 151
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 170
mi
from
Great Neck, NY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 170
mi
from
Great Neck, NY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 203
mi
from
New Hyde Park, NY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 203
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 205
mi
from
Fayetteville, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 205
mi
from
Fayetteville, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 104
mi
from
Greensboro, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 104
mi
from
Greensboro, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 194
mi
from
Hickory, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 194
mi
from
Hickory, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 412
mi
from
Wilmington, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 412
mi
from
Wilmington, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 172
mi
from
Beavercreek, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 172
mi
from
Beavercreek, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 223
mi
from
Cincinnati, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 223
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 173
mi
from
Dayton, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 173
mi
from
Dayton, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 208
mi
from
Franklin, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 208
mi
from
Franklin, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 171
mi
from
Huber Heights, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 171
mi
from
Huber Heights, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 219
mi
from
Lima, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 219
mi
from
Lima, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 232
mi
from
Wadsworth, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 232
mi
from
Wadsworth, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 236
mi
from
Oklahoma City, OK
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 236
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 273
mi
from
Tulsa, OK
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 273
mi
from
Tulsa, OK
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 220
mi
from
Levittown, PA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 220
mi
from
Levittown, PA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 248
mi
from
East Providence, RI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 248
mi
from
East Providence, RI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 404
mi
from
Columbia, SC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 404
mi
from
Columbia, SC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 265
mi
from
Gaffney, SC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 265
mi
from
Gaffney, SC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 246
mi
from
Rapid City, SD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 246
mi
from
Rapid City, SD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 261
mi
from
Sioux Falls, SD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 261
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 134
mi
from
Chattanooga, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 134
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 121
mi
from
Franklin, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 121
mi
from
Franklin, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 189
mi
from
Hermitage, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 189
mi
from
Hermitage, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 133
mi
from
Jackson, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 133
mi
from
Jackson, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 109
mi
from
Knoxville, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 109
mi
from
Knoxville, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 266
mi
from
Memphis, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 266
mi
from
Memphis, TN
Click here to add this to my saved trials